Peter M. Castleman - 09 Jan 2026 Form 4 Insider Report for Caris Life Sciences, Inc.

Reporting relationship: Director
Issuer ticker: CAI on Nasdaq
Reported as of: 09 Jan 2026
Net transaction value: +$46,500
SEC form: 4
Accepted by SEC: 13 Jan 2026, 18:37:09 UTC
Prior SEC filing: 17 Jun 2025
Next SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton, Attorney-in-Fact

Key filing fact

Peter M. Castleman filed Form 4 for Caris Life Sciences, Inc. on 13 Jan 2026.

Key facts

This page summarizes Peter M. Castleman's Form 4 filing for Caris Life Sciences, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Jan 2026, 18:37.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: +$46,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239594 Primary reporting owner

CASTLEMAN PETER M

Relationship: Director
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton, Attorney-in-Fact
Signature date: 13 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Options Exercise

Transaction value: $46,500
Shares: +2,500
Change %: +16%
Price: $18.60
Shares after: 18,629
Date: 09 Jan 2026
Ownership: Direct

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 100,000
Date: 09 Jan 2026
Ownership: By Family Trust

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,270,906
Date: 09 Jan 2026
Ownership: By CLS-PF-SPE, LLC
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAI transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -2,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 09 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,500
Exercise price: $18.60
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Footnote F2

The stock option is fully vested and exercisable. These securities were previously reported on the Reporting Person's Form 3.